Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors
Ning Qing Liu, Irene Paassen, Lars Custers, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Epigenomic heterogeneity as a source of tumour evolution
Marthe Laisné, Mathieu Lupien, Céline Vallot
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers
Daniela Perotti, Maureen J. O’Sullivan, Amy L. Walz, et al.
Nature Reviews Urology (2025)
Closed Access | Times Cited: 1
WD Repeat Domain 5 Inhibitors for Cancer Therapy: Not What You Think
April M. Weissmiller, Stephen W. Fesik, William P. Tansey
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 274-274
Open Access | Times Cited: 7
Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology
Wan Ying Tan, Snigdha Nagabhyrava, Olivia Ang-Olson, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6533-6565
Open Access | Times Cited: 4
SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1
Octavio A. Trejo-Villegas, Priscila Pineda-Villegas, Leonel Armas‐López, et al.
Cancer Gene Therapy (2025)
Open Access
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target
Fabio Sias, Stefano Zoroddu, Rossana Migheli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1973-1973
Open Access
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Florian Perner, Tobias Berg, Daniel Sasca, et al.
International Journal of Cancer (2025)
Open Access
Proximal and classic epithelioid sarcomas are distinct molecular entities defined by MYC/GATA3 and SOX17/endothelial markers, respectively
Luca Sigalotti, Anna Maria Frezza, Marta Sbaraglia, et al.
Modern Pathology (2024) Vol. 38, Iss. 1, pp. 100647-100647
Open Access | Times Cited: 1
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup ATRTs
Brian Golbourn, Ben Ho, Andrew Bondoc, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 10, pp. 1895-1911
Closed Access
Development and epigenetic regulation of Atypical teratoid/rhabdoid tumors (AT/RTs) in the context of cell-of-origin and halted cell differentiation
Laura Huhtala, Göktuğ Karabiyik, Kirsi J. Rautajoki
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access
Page 1

Scroll to top